GEN News Highlights

PerkinElmer Acquires Arnel to Fortify Services for the Biofuels Industry

(Page
1
of
1)

PerkinElmer has taken over Arnel to bolster its application-focused expertise in the biofuels and hydrocarbon-processing industries. PerkinElmer also reports that the acquisition is an important strategic initiative to expand its chromatography portfolio.

Arnel focuses on custom-engineered solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets. Over the past 18 years, Arnel served as PerkinElmer’s exclusive supplier of gas sampling valve solutions.

“In addition, we believe that combining Arnel’s technologies with PerkinElmer’s chromatography capabilities will help our customers develop cleaner, petroleum-based products to help reduce their impact on the environment as well as assist in manufacturing more cost-effective petroleum products.”

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.

GEN Poll

Secure Science

Should bans on science education, of the sort imposed on Iranians hoping to study physics and engineering in the United States, encompass other nationals and other fields of study, including biotechnology?

No. Such bans could easily get out of control, preventing the sharing and growth of knowledge.

Yes. The potential, for example, for the development of bioweapons if biotech information gets into the wrong hands must be minimized.

No. Such bans could easily get out of control, preventing the sharing and growth of knowledge.

57.3%

Yes. The potential, for example, for the development of bioweapons if biotech information gets into the wrong hands must be minimized.

If you have any questions about your subscription, click
hereto email us or call at (914) 740-2189.

You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
environment. Subscribe
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
more.